May/June 2026
May/June 2026 | Features
Pearls and Pitfalls of Treating GA and Wet AMD
Concurrent therapy can pose clinical challenges. Here’s how you can manage these patients and maximize outcomes.
Sean D. Adrean, MD, FAAO, and Wesley Han, BS
May/June 2026 | Visually Speaking
Peripheral Firestorm: The Ischemic Retina
Proliferative disease may still be progressing despite good vision.
Apoorva Jadhav, MBBS, DNB; Unnikrishnan Nair, MS, FRCS, FMRF; and Manoj Soman, DNB, FICO, FRCS
May/June 2026 | Surgical Pearls
Fibrin Glue in Retina Surgery
This tried-and-true tool may be a valuable tamponade alternative.
Lawrence Chan, MD; Tanner Frediani, MD; and Gaurav K. Shah, MD
May/June 2026 | Features
Landmark Trials in AMD
A summary of the clinical trials that have shaped—and continue to shape—how we treat AMD.
Saghar Bagheri, MD, PHD; Alberto Quarta, MD; Rouzbeh Abbasgholizadeh, MD; Alessandro Feo, MD; Paolo Forte, MD; David Sarraf, MD; Michael S. Ip, MD; and SriniVas R. Sadda, MD, FARVO
Popular Articles
April 2026 Insert
One to Watch: Samir N. Patel, MD
Samir N. Patel, MD
March 2026 Supplement | Digital Supplement
From Vascular Curiosity to Neurodegenerative Disease: A Consensus Statement for the Diagnosis and Management of Macular Telangiectasia Type 2
Lejla Vajzovic, MD, FASRS; Sophie Bakri, MD; W. Lloyd Clark, MD; Diana Do, MD; Dean Eliott, MD; Roger Goldberg, MD; and Dante Pieramici, MD
May/June 2026 Supplement | Editorial
The Economics Of Care
Alan Ruby, MD
January/February 2026 Supplement
Introducing ENCELTO Into Retina Practices
David Chin Yee, MD, and Jiong Yan, MD